Fortress Biotech 9.375% Series A Preferred Stock (FBIOP)

• Market cap: $64.7M
• 1 day: 0.43%
• 5 days: -0.16%
• 1 month: -6.07%
• 3 months: 31.2%
• 6 months: 55.01%
• Year to date: 85.83%
• 1 year: 174.82%
• 5 years: -27.41%
• 10 years: -22.14%
• Sector: Healthcare
• Industry: Biotechnology

About: Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

Employees: 78